<DOC>
	<DOCNO>NCT00144625</DOCNO>
	<brief_summary>This open-label , extension , Phase III study evaluate long-term safety , efficacy PK MRA patient pJIA participate Study MRA318JP .</brief_summary>
	<brief_title>Long-term Treatment Study MRA Polyarticular Juvenile Idiopathic Arthritis ( pJIA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<criteria>Inclusion criterion Of patient receive three infusion MRA previous study last observation conduct patient problem safety previous study '' Exclusion criterion Patients enrol 3 month completion previous study Patients receive follow since completion previous study initiation treatment present study 1 . DMARDs immunosuppressants 2 . Intravenous intramuscular injection corticosteroid 3 . Plasma exchange therapy 4 . Other drug therapy may affect evaluation drug efficacy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>